08-2026
|
A Multiple Ascending Dose Trial Investigating Safety, To
A Multiple Ascending Dose Trial Investigating Safety, To
|
03-2026
|
Human Gene Transfer/Macrophage Cell Transplantation Ther
Human Gene Transfer/Macrophage Cell Transplantation Ther
|
01-2026
|
Rituximab Followed by Abatacept for Prevention or Revers
Rituximab Followed by Abatacept for Prevention or Revers
|
10-2025
|
A Phase 2A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Subtype-Selective JAK Inhibitors for Preservation of Pancreatic B Cell Function in Newly Diagnosed Type 1 Diabetes Mellitus
A Phase 2A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Subtype-Selective JAK Inhibitors for Preservation of Pancreatic B Cell Function in Newly Diagnosed Type 1 Diabetes Mellitus
|
03-2025
|
Limited Competition: Continued Follow-up of Subjects and
Limited Competition: Continued Follow-up of Subjects and
|
09-2024
|
Continuation of the Data Coordinating Center for Type 1 Diabetes TrailNet (U01)
Continuation of the Data Coordinating Center for Type 1 Diabetes TrailNet (U01)
|
07-2024
|
Type 1 Diabetes Genetic Risk Score in TrialNet
Type 1 Diabetes Genetic Risk Score in TrialNet
|
07-2024
|
Understanding pancreatic endocrine and exocrine loss in
Understanding pancreatic endocrine and exocrine loss in
|
12-2023
|
RSBQ Datasets
RSBQ Datasets
|
08-2023
|
TN25: Rituximab Followed by Abatacept for Prevention or
TN25: Rituximab Followed by Abatacept for Prevention or
|
06-2023
|
Atypical Diabetes Research and Evaluation (CADRE)
Atypical Diabetes Research and Evaluation (CADRE)
|
05-2023
|
Natural History of SSADHD, a Heritable Disorder of GABA Metabolism
Natural History of SSADHD, a Heritable Disorder of GABA Metabolism
|
03-2023
|
Follow-Up on Subjects, Integrative Data Analysis and Measurement of Viral Antibodies in the Environmental Determinants of Diabetes in The Young TEDDY U01
Follow-Up on Subjects, Integrative Data Analysis and Measurement of Viral Antibodies in the Environmental Determinants of Diabetes in The Young TEDDY U01
|
09-2022
|
Data Coordinating Center for Type 1 Diabetes TrialNet (U
Data Coordinating Center for Type 1 Diabetes TrialNet (U
|
08-2022
|
NIDDK Follow-up on Subjects and Immunological Assessment
NIDDK Follow-up on Subjects and Immunological Assessment
|
06-2022
|
VCRC EGPA Project
VCRC EGPA Project
|
12-2021
|
Follow-Up of Children Diagnosed with Diabetes
Follow-Up of Children Diagnosed with Diabetes
|
08-2021
|
The Study of Epigenetics and Infections in the Environme
The Study of Epigenetics and Infections in the Environme
|
07-2021
|
Rett Syndrome, MECP2 Duplications and Rett Related Disor
Rett Syndrome, MECP2 Duplications and Rett Related Disor
|
03-2021
|
Multicenter Interventional Lymphangioleiomyomatosis Earl
Multicenter Interventional Lymphangioleiomyomatosis Earl
|
01-2021
|
Clinical Research Consortium for Spinocerebellar Ataxias
Clinical Research Consortium for Spinocerebellar Ataxias
|
12-2020
|
USF - U01 NS104326 (Database) - Year 2
USF - U01 NS104326 (Database) - Year 2
|
09-2020
|
Osteogenesis Imperfecta Foundation Contact Registry
Osteogenesis Imperfecta Foundation Contact Registry
|
08-2020
|
Vasculitis Clinical Research Consortium FY 19-20
Vasculitis Clinical Research Consortium FY 19-20
|
08-2020
|
USF Support for the Rett-releated Disorders
USF Support for the Rett-releated Disorders
|
07-2020
|
Rare Lung Diseases Consortium (RLD) PharmPaP Project
Rare Lung Diseases Consortium (RLD) PharmPaP Project
|
07-2020
|
CMT COVid19 Survey Development and Distribution
CMT COVid19 Survey Development and Distribution
|
07-2020
|
Primary Immune Deficiency Treatment Consortium
Primary Immune Deficiency Treatment Consortium
|
06-2020
|
The Environmental Determinants of Diabetes in the Youth Study (TEDDY) Data Coordinating Center
The Environmental Determinants of Diabetes in the Youth Study (TEDDY) Data Coordinating Center
|
06-2020
|
NIDDK Type 1 Diabetes TrialNet Data
NIDDK Type 1 Diabetes TrialNet Data
|
04-2020
|
T Cell Receptor Sequencing Living Biobank Study
T Cell Receptor Sequencing Living Biobank Study
|
03-2020
|
CGM Metrics Identify Dysglycemic States in Subjects with
CGM Metrics Identify Dysglycemic States in Subjects with
|
11-2019
|
DMCC for the Vasculitis Patient-Powered Research Network (V-PPRN)
DMCC for the Vasculitis Patient-Powered Research Network (V-PPRN)
|
11-2019
|
TrialNet Small Group Meetings
TrialNet Small Group Meetings
|
08-2019
|
Sterol and Isoprenoid Diseases Consortium
Sterol and Isoprenoid Diseases Consortium
|
08-2019
|
Vasculitis Clinical Research Consortium
Vasculitis Clinical Research Consortium
|
07-2019
|
Genetic Disorder of Mucocilary Clearance
Genetic Disorder of Mucocilary Clearance
|
07-2019
|
Ultragenyx Pharmaceutical Longitudinal Study of Urea Cycle Disorders (UCDC5101) Data Request #2
Ultragenyx Pharmaceutical Longitudinal Study of Urea Cycle Disorders (UCDC5101) Data Request #2
|
07-2019
|
Brittle Bone disorders Consortium of the Rare Disease Clinical Network
Brittle Bone disorders Consortium of the Rare Disease Clinical Network
|
07-2019
|
VPRN CHOICE - The Comparative Health Outcomes in immune-mediated disease Collaborative (CHOICE) Study
VPRN CHOICE - The Comparative Health Outcomes in immune-mediated disease Collaborative (CHOICE) Study
|
07-2019
|
RLDC: Molecular Pathway-Driven Diagnostics & Therapeutics for Rare Lung Diseases
RLDC: Molecular Pathway-Driven Diagnostics & Therapeutics for Rare Lung Diseases
|
07-2019
|
Genetic Disorders of Mucociliary Clearance
Genetic Disorders of Mucociliary Clearance
|
07-2019
|
RTT & MECP2 - Related Disorders
RTT & MECP2 - Related Disorders
|
07-2019
|
Rare Diseases Data Management and Coordinating Center
Rare Diseases Data Management and Coordinating Center
|
06-2019
|
Brittle Bone DIsorders Consortium of the RDCRN
Brittle Bone DIsorders Consortium of the RDCRN
|
06-2019
|
Vasculitis Clinical Research Consortium
Vasculitis Clinical Research Consortium
|
06-2019
|
Sterol and Isoprenoid Diseases Consortium
Sterol and Isoprenoid Diseases Consortium
|
06-2019
|
Trial to Reduce IDDM in the Genetically at Risk (TRIGR)
Trial to Reduce IDDM in the Genetically at Risk (TRIGR)
|
03-2019
|
Abatacept (CTLA4Ig) for the Treatment of Relapsing, Non-
Abatacept (CTLA4Ig) for the Treatment of Relapsing, Non-
|
03-2019
|
Abatacept (CTLA4-lg) for the Treatment of Relapsing, Non
Abatacept (CTLA4-lg) for the Treatment of Relapsing, Non
|
02-2019
|
North American Charcot Marie Tooth (CMT) Network
North American Charcot Marie Tooth (CMT) Network
|
12-2018
|
Establish a Data Coordinating Center (DCC) for the Consortium for Identification of Environmental Triggers of Type 1 Diabetes.
Establish a Data Coordinating Center (DCC) for the Consortium for Identification of Environmental Triggers of Type 1 Diabetes.
|
08-2018
|
Vasculitis Clinical Research Consortium
Vasculitis Clinical Research Consortium
|
07-2018
|
Brittle Bone Disorders Consortium of the Rare Disease Cl
Brittle Bone Disorders Consortium of the Rare Disease Cl
|
06-2018
|
Effect of Early Diet and Virus Infections on Immune Regu
Effect of Early Diet and Virus Infections on Immune Regu
|
06-2018
|
TRIGR Study Data Management Unit (TRIGR DMU
TRIGR Study Data Management Unit (TRIGR DMU
|
05-2018
|
Facilitate the Implementation of a Single IRB (sIRB) Mod
Facilitate the Implementation of a Single IRB (sIRB) Mod
|
04-2018
|
PhaseRx- Longitudinal Study of Urea Cycle Disorders (UCD
PhaseRx- Longitudinal Study of Urea Cycle Disorders (UCD
|
04-2018
|
Healthcore (V-PPRN)
Healthcore (V-PPRN)
|
04-2018
|
Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR)
Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR)
|
03-2018
|
Aeglea-Longitudinal Study of Urea Cycle Disorders (UCDC5
Aeglea-Longitudinal Study of Urea Cycle Disorders (UCDC5
|
09-2017
|
CC*DNI Networking Infrastructure: Campus Research Network - High Bandwidth Private Network Path for Research Data from Experiment to Analysis and Back Again at USF
CC*DNI Networking Infrastructure: Campus Research Network - High Bandwidth Private Network Path for Research Data from Experiment to Analysis and Back Again at USF
|
08-2017
|
The Environmental Determinants of Diabetes in the Youth Study (TEDDY) Data Coordinating Center
The Environmental Determinants of Diabetes in the Youth Study (TEDDY) Data Coordinating Center
|
08-2017
|
Anti-CD3 (teplizumab) for Prevention of Diabetes i
Anti-CD3 (teplizumab) for Prevention of Diabetes i
|
07-2017
|
Dimension Therapeutics Longitudinal Study of Urea Cycle
Dimension Therapeutics Longitudinal Study of Urea Cycle
|
07-2017
|
Healthy Mind Healthy You: A Dose Finding Study of Mindfu
Healthy Mind Healthy You: A Dose Finding Study of Mindfu
|
06-2017
|
NIDDK Type 1 Diavetes TrialNel Data Coordinating Center
NIDDK Type 1 Diavetes TrialNel Data Coordinating Center
|
06-2017
|
NIDDK Type 1 Diabetes TrialNet Data Coordinating Center
NIDDK Type 1 Diabetes TrialNet Data Coordinating Center
|
05-2017
|
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) and Pegylated GCSF in New Type 1 Diabetes Protocol TN-19.
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) and Pegylated GCSF in New Type 1 Diabetes Protocol TN-19.
|
05-2017
|
Antithymocyte Globulin (ATG) and Pegylated Granulocyte C
Antithymocyte Globulin (ATG) and Pegylated Granulocyte C
|
05-2017
|
Novel Methods for the Conduct of Clinical Trials
Novel Methods for the Conduct of Clinical Trials
|
05-2017
|
TN-19-ATG-GCSF DCC-Phase II Clinical Trial in New Onset
TN-19-ATG-GCSF DCC-Phase II Clinical Trial in New Onset
|
04-2017
|
TN19-ATG-GCSF
TN19-ATG-GCSF
|
01-2017
|
North American Charcot-Marie-Tooth (CMT) Network
North American Charcot-Marie-Tooth (CMT) Network
|
12-2016
|
Establish a Data Coordinating Center (DCC) for the Conso
Establish a Data Coordinating Center (DCC) for the Conso
|
09-2016
|
GLEEVEC (Imatinib Messylate) New Onset Study
GLEEVEC (Imatinib Messylate) New Onset Study
|
08-2016
|
Vasculitis Clinical Research Consortium
Vasculitis Clinical Research Consortium
|
08-2016
|
Adaptation and Validation of PROMIS for us in Vasculitis
Adaptation and Validation of PROMIS for us in Vasculitis
|
08-2016
|
Adaption and Validation of PROMIS for use in Vasculitis
Adaption and Validation of PROMIS for use in Vasculitis
|
08-2016
|
Data Coordinating Center for the Consortium for Identification of Environmental Determinants of Diabetes in the Young (TEDDY) Study (UC4)
Data Coordinating Center for the Consortium for Identification of Environmental Determinants of Diabetes in the Young (TEDDY) Study (UC4)
|
07-2016
|
Brittle Bone Disorders Consortium of the Rare Disease
Brittle Bone Disorders Consortium of the Rare Disease
|
07-2016
|
Rare Lung Disease Consortium - U54 (RLD)
Rare Lung Disease Consortium - U54 (RLD)
|
07-2016
|
Genetic Disorders of Mucociliary Clearance
Genetic Disorders of Mucociliary Clearance
|
07-2016
|
Rare Disease Research
Rare Disease Research
|
06-2016
|
HCT T1D Prevention: Data Analysis Initiative
HCT T1D Prevention: Data Analysis Initiative
|
06-2016
|
Trial to Reduce IDDM in the Genetically at Risk (TRIGR) Data Management Unit
Trial to Reduce IDDM in the Genetically at Risk (TRIGR) Data Management Unit
|
05-2016
|
Novel Methods for the Conduct of Clinical Trials
Novel Methods for the Conduct of Clinical Trials
|
04-2016
|
Anti-Inflammatory as Small Drug as Adjunctive Therapy to
Anti-Inflammatory as Small Drug as Adjunctive Therapy to
|
10-2015
|
Research Services Agreement ACZ88512201
Research Services Agreement ACZ88512201
|
08-2015
|
The Vasculitis Patient Powered Research Network
The Vasculitis Patient Powered Research Network
|
07-2015
|
TrialNet Cap Reimb NIDDK Type 1 Diabetes TrialNet
TrialNet Cap Reimb NIDDK Type 1 Diabetes TrialNet
|
07-2015
|
NIDDK Type 1 Diabetes TrialNet Data Coordinating Center
NIDDK Type 1 Diabetes TrialNet Data Coordinating Center
|
06-2015
|
The Vasculitis Patient Powered Research Network
The Vasculitis Patient Powered Research Network
|
05-2015
|
Novel Methods for the Conduct of Clinical Trials
Novel Methods for the Conduct of Clinical Trials
|
05-2015
|
SunCoast CCOP Research Base at the University of South Florida
SunCoast CCOP Research Base at the University of South Florida
|
12-2014
|
Patient-Reported Outcomes for Vasculitis
Patient-Reported Outcomes for Vasculitis
|
12-2014
|
North American Charcot Marie Tooth (CMT) Network
North American Charcot Marie Tooth (CMT) Network
|
10-2014
|
UCD Symposium Graphic Design
UCD Symposium Graphic Design
|
10-2014
|
Hyperion
Hyperion
|
09-2014
|
GLEEVEC (Imatinib Mesylate) New Onset Study
GLEEVEC (Imatinib Mesylate) New Onset Study
|
09-2014
|
Multicenter International Lymphangioleiomyomatosis Effic
Multicenter International Lymphangioleiomyomatosis Effic
|
08-2014
|
Vasculitis Clinical Research Consortium
Vasculitis Clinical Research Consortium
|
08-2014
|
Adaptation and Validation of PROMIS for use in Vasculiti
Adaptation and Validation of PROMIS for use in Vasculiti
|
08-2014
|
Vasculitis Clinical Research Consortium
Vasculitis Clinical Research Consortium
|
08-2014
|
Vasculitis Clinical Research Consortium
Vasculitis Clinical Research Consortium
|
06-2014
|
Follow-up of Children Diagnosed with Diabetes
Follow-up of Children Diagnosed with Diabetes
|
05-2014
|
DMI Study - Interactive Voice Response System CINCH IVR
DMI Study - Interactive Voice Response System CINCH IVR
|
12-2013
|
Data Management and Coordinating Center (DMCC)
Data Management and Coordinating Center (DMCC)
|
10-2013
|
LAM Clinics Registry Database
LAM Clinics Registry Database
|
10-2013
|
LAM Clinics Registry Database
LAM Clinics Registry Database
|
10-2013
|
Nobelpharma Data Agreement
Nobelpharma Data Agreement
|
06-2013
|
Statistical Analyses of Virus Antibody Data Generated by the University of Tampere in the TRIGR Study
Statistical Analyses of Virus Antibody Data Generated by the University of Tampere in the TRIGR Study
|
06-2013
|
AIRmax as Sensitive Measure of Beta Cell Function in at Risk Individuals
AIRmax as Sensitive Measure of Beta Cell Function in at Risk Individuals
|
04-2013
|
Phase I Study of Lenalidomide in Combination with 5-azacytidine in Patients with Advanced Myelodysplastic Syndrome (MDS)
Phase I Study of Lenalidomide in Combination with 5-azacytidine in Patients with Advanced Myelodysplastic Syndrome (MDS)
|
03-2013
|
Conference on Clinical Research for Rare Diseases
Conference on Clinical Research for Rare Diseases
|
07-2012
|
Reproductive Health in Men and Women with Vasculitis
Reproductive Health in Men and Women with Vasculitis
|
05-2012
|
Concurrent Pilot Studies in Giant Cell Arteries (GCA) and Takayasu's Arterities
Concurrent Pilot Studies in Giant Cell Arteries (GCA) and Takayasu's Arterities
|
12-2011
|
Vasculitis Clinical Research Consortium 2
Vasculitis Clinical Research Consortium 2
|
09-2011
|
Trial to Reduce IDDM in the Genetically at Risk (TRIGR) Data Management Unit
Trial to Reduce IDDM in the Genetically at Risk (TRIGR) Data Management Unit
|
08-2011
|
Identification and Validation of Biomarkers for Vasulitis
Identification and Validation of Biomarkers for Vasulitis
|
08-2011
|
Rare Diseases Data Management and Coordinating Cen
Rare Diseases Data Management and Coordinating Cen
|
08-2011
|
Nervous System Channelopathies: Pathogenesis and T
Nervous System Channelopathies: Pathogenesis and T
|
08-2011
|
Inherited Neuropathies Consortium (RDCRC)
Inherited Neuropathies Consortium (RDCRC)
|
06-2011
|
Trial to Reduce IDDM in the Genetically at Risk (TRIGR) Data Management Unit
Trial to Reduce IDDM in the Genetically at Risk (TRIGR) Data Management Unit
|
06-2011
|
Trial to Reduce IDDM in the Genetically at Risk (TRIGR) Data Management Unit
Trial to Reduce IDDM in the Genetically at Risk (TRIGR) Data Management Unit
|
03-2011
|
Conference on Clinical Research for Rare Disease
Conference on Clinical Research for Rare Disease
|
01-2011
|
PROMIS Network Center (Subcontract 622.02833)
PROMIS Network Center (Subcontract 622.02833)
|
12-2010
|
Anti-IL-1 Treatment in New-onset Type 1 Diabetes: Statistical Coordination
Anti-IL-1 Treatment in New-onset Type 1 Diabetes: Statistical Coordination
|
12-2010
|
The LAM Foundation Project - DMCC for the MILES Trial
The LAM Foundation Project - DMCC for the MILES Trial
|
08-2010
|
Nervous System Channelopathies: Pathogenesis and Treatment
Nervous System Channelopathies: Pathogenesis and Treatment
|
08-2010
|
Vasulitis Clinical Research Consortium
Vasulitis Clinical Research Consortium
|
07-2010
|
Rare Disease Research
Rare Disease Research
|
07-2010
|
Rare Disease CRC for New Therapies and New Diagnostics
Rare Disease CRC for New Therapies and New Diagnostics
|
07-2010
|
Genetic Disorder of Mucocilary Clearance
Genetic Disorder of Mucocilary Clearance
|
06-2010
|
Trial to Reduce IDDM in the Genetically at Risk( (TIGR) Data Management Unit
Trial to Reduce IDDM in the Genetically at Risk( (TIGR) Data Management Unit
|
05-2010
|
H Lee Moffitt Cancer Center CCOP Research Base
H Lee Moffitt Cancer Center CCOP Research Base
|
05-2010
|
H Lee Moffitt Cancer Center CCOP Research Base
H Lee Moffitt Cancer Center CCOP Research Base
|
12-2009
|
Web-Based Telegenetics Project
Web-Based Telegenetics Project
|
10-2009
|
Hyperion - Consultation and Data Analysis
Hyperion - Consultation and Data Analysis
|
07-2009
|
The Data and Technology Coordinating Center for Mexiletine Study
The Data and Technology Coordinating Center for Mexiletine Study
|
06-2009
|
Trial to Reduce IDDM in the Genetically at Risk (TRIGR) Data Management Unit
Trial to Reduce IDDM in the Genetically at Risk (TRIGR) Data Management Unit
|
06-2009
|
OId Data Collection Center for Linked Clinical Research Centers
OId Data Collection Center for Linked Clinical Research Centers
|
05-2009
|
H Lee Moffitt Cancer Center CCOP Research Base
H Lee Moffitt Cancer Center CCOP Research Base
|
03-2009
|
Type 1 Diabetes TrialNet: Coordinating Center
Type 1 Diabetes TrialNet: Coordinating Center
|
01-2009
|
Advanced Cancer Detection Center II
Advanced Cancer Detection Center II
|
10-2008
|
NF Consortium Operation Center Protocol 102 mTOR
NF Consortium Operation Center Protocol 102 mTOR
|
06-2008
|
Trial to Reduce IDDM in the Genetically at Risk (TRIGR) Data management Unit
Trial to Reduce IDDM in the Genetically at Risk (TRIGR) Data management Unit
|
06-2008
|
Type 1 Diabetes Trial net
Type 1 Diabetes Trial net
|
12-2007
|
Cystic Fibrosis Treatment Development Network
Cystic Fibrosis Treatment Development Network
|
08-2007
|
Data Coordinating Center (TEDDY)
Data Coordinating Center (TEDDY)
|
08-2007
|
TEDDY Data Coordinating Center
TEDDY Data Coordinating Center
|
07-2007
|
Rare Diseases Data & Technology Coordinating Center
Rare Diseases Data & Technology Coordinating Center
|
06-2007
|
Type 1 Diabetes Trial Net
Type 1 Diabetes Trial Net
|
05-2007
|
H Lee Moffitt Cancer Center CCOP Research Base
H Lee Moffitt Cancer Center CCOP Research Base
|
12-2006
|
Florida Neurofibromatosis Research Network
Florida Neurofibromatosis Research Network
|
12-2006
|
Florida Neurofibromatosis Research Network
Florida Neurofibromatosis Research Network
|
09-2006
|
Vasculitis Outcome Measures: Development and Validation
Vasculitis Outcome Measures: Development and Validation
|
05-2006
|
H. Lee Moffitt Cancer Center CCOP Research Base
H. Lee Moffitt Cancer Center CCOP Research Base
|
05-2006
|
Targeted Drug Therapy for LGL Leukemia
Targeted Drug Therapy for LGL Leukemia
|
03-2006
|
Cystic Fibrosis Treatment Development Network
Cystic Fibrosis Treatment Development Network
|
12-2005
|
DTP-1 Twin Study
DTP-1 Twin Study
|
07-2005
|
Rare Diseases Data and Technology Center
Rare Diseases Data and Technology Center
|
06-2005
|
Nutritional Primary Prevention of Type 1 Diabetes
Nutritional Primary Prevention of Type 1 Diabetes
|
06-2005
|
Type 1 Diabetes Trial Net
Type 1 Diabetes Trial Net
|
05-2005
|
H. Lee Moffitt Cancer Center CCOP Research Base
H. Lee Moffitt Cancer Center CCOP Research Base
|
11-2004
|
Antibodies to Recombinant Autoantigens-Predict
Antibodies to Recombinant Autoantigens-Predict
|
06-2004
|
Nutritional Primary Prevention of Type I Diabetes
Nutritional Primary Prevention of Type I Diabetes
|
06-2003
|
TRIGR: Trial to Reduce IDDM in the Genetically at Risk
TRIGR: Trial to Reduce IDDM in the Genetically at Risk
|
06-2003
|
Nutritional Primary Prevention of Type I Diabetes
Nutritional Primary Prevention of Type I Diabetes
|
07-2002
|
Antibodies to Recombinant Autoantigens: Prediction/Immunogenetics
Antibodies to Recombinant Autoantigens: Prediction/Immunogenetics
|
05-2002
|
DQB*0602 Relatives: Mechanisms for Diabetes Protection
DQB*0602 Relatives: Mechanisms for Diabetes Protection
|